Bladder Cancer Canada
STAR RATINGCi's Star Rating is calculated based on the following independent metrics: |
✔+
FINANCIAL TRANSPARENCY
Audited financial statements for current and previous years available on the charity’s website.
B-
RESULTS REPORTING
Grade based on the charity's public reporting of the work it does and the results it achieves.
n/r
DEMONSTRATED IMPACT
The demonstrated impact per dollar Ci calculates from available program information.
NEED FOR FUNDING
Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.
80%
CENTS TO THE CAUSE
For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 80 cents are available for programs.
My anchor
OVERVIEW
About Bladder Cancer Canada:
Founded in 2009 by two Canadians diagnosed with bladder cancer, Bladder Cancer Canada (BCC) aims to improve the level of support available for those diagnosed with the disease. BCC reports there are currently 80,000 Canadians living with bladder cancer with 12,000 diagnoses annually. Blader cancer is the fifth most common cancer in Canada. BCC reports that it is highly underfunded, ranking 21st out of the top 25 research funded cancers. Due to a high recurrence rate of 60-70%, bladder cancer is also the most expensive cancer type to treat on a per-patient basis.
Bladder Cancer Canada’s mission is three-fold: support bladder cancer patients; increase awareness and education; and fund bladder cancer research. These pillars align with the charity’s three program areas: Research, Awareness, and Patient Support.
Research represents 47% of program spending in F2020. The charity reports it spent $253k on research in F2020. However, the charity’s financial statements report research expenses of $128k and a $100k grant to Canadian Bladder Cancer Information System (CBCIS). BCC distributes annual $50,000 grants for basic bladder cancer research. In F2020, Dr. Black and Dr. Eigl from the University of British Columbia both received a grant. The researchers are working with genes that can promote cancer growth and identify bladder cancer treatments. Both recipients are members of the charity’s Medical Advisory and Research Board.
Bladder Cancer Canada is a major sponsor of CBCIS, which launched in F2014. CBCIS is a database that collects treatment outcome data on bladder cancer patients from 14 health centers across Canada. The goal is to use this data to improve treatment and clinical management practices for patients. The database has information from over 5,400 patients as of F2020.
Awareness represents 42% of program spending in F2020. BCC works with patients, doctors, and the general public to increase awareness about bladder cancer. BCC has 2,024 Facebook followers and 448 Instagram followers, a 5% and 30% increase over F2019 respectively. The charity’s website received 223,340 views in F2020. BCC reports it launched a bladder cancer blog in December of 2020 and a podcast for Bladder Cancer Awareness Month in May.
Patient Support accounts for the final 11% of program spending in F2020. BCC posts online resources, hosts meetings and webinars, runs an online discussion forum, and provides one-to-one support through its One2One program. The online discussion forum had 4,975 visits in F2020, a 15% increase over F2019. The charity also distributed 9,482 patient guidebooks.
My anchor
Results and Impact
Charity Intelligence did not find any quantified outcomes reported on Bladder Cancer Canada's website. This charity is not yet rated on impact (n/r).
My anchor
Finances
Bladder Cancer Canada has donations of $971k in F2020. The charity received $78k in government funding, representing 7% of total revenues. Administrative costs are 16% of revenues (less investment income) and fundraising costs are 4% of donations. This results in total overhead spending of 20%. For every dollar donated, 80 cents go to the cause. This is within Ci’s reasonable range for overhead spending.
BCC has $986k in funding reserves. The charity could cover 125% or around one year and three months of annual program costs with current reserves.
This charity report is an update that has been sent to Bladder Cancer Canada for review. Changes and edits may be forthcoming.
Updated on July 22, 2021 by Brenleigh Jebb.
Financial Review
Fiscal year ending December
|
2020 | 2019 | 2018 |
|---|---|---|---|
| Administrative costs as % of revenues | 16.1% | 11.1% | 8.3% |
| Fundraising costs as % of donations | 3.9% | 9.2% | 10.5% |
| Total overhead spending | 20.0% | 20.3% | 18.8% |
| Program cost coverage (%) | 124.9% | 116.8% | 128.6% |
Summary Financial StatementsAll figures in $s |
2020 | 2019 | 2018 |
|---|---|---|---|
| Donations | 971,161 | 1,065,466 | 972,603 |
| Government funding | 78,257 | 465 | 75 |
| Investment income | 3,919 | 12,155 | 17,313 |
| Total revenues | 1,053,337 | 1,078,086 | 989,991 |
| Program costs | 689,171 | 719,176 | 609,660 |
| Grants | 100,000 | 75,000 | 93,197 |
| Administrative costs | 169,170 | 118,339 | 80,239 |
| Fundraising costs | 38,037 | 97,505 | 102,229 |
| Cash flow from operations | 56,959 | 68,066 | 104,666 |
| Funding reserves | 985,613 | 927,345 | 903,948 |
Note: Ci reported administrative, program, and fundraising costs from the charity’s T3010 filings with the CRA. All contributions made by BCC to the CBCIS project are included in grants. Loss on disposal of investments is non-cash and thus not reported as an expense in Ci’s analysis, lowering total expenses by $10k in F2018.
Salary Information
$350k + |
0 |
$300k - $350k |
0 |
$250k - $300k |
0 |
$200k - $250k |
0 |
$160k - $200k |
0 |
$120k - $160k |
1 |
$80k - $120k |
0 |
$40k - $80k |
2 |
< $40k |
0 |
Information from most recent CRA Charities Directorate filings for F2020
My anchor
Comments & Contact
Comments added by the Charity:
Charity Contact
This email address is being protected from spambots. You need JavaScript enabled to view it.